Due to a necessary upgrade of the UK NEQAS LI Web Server, the Participant Hub and Data Entry Forms will be unavailable from Saturday 6th March until Monday 8th March. During this time you will not be anle to enter any trial results online, amend any contact details and you will not be able to re-register for the 2021-2022 financial year.
We apologise for any inconvenience caused and as soon as the Participant Hub and Data Entry Forms are available we will inform all participants.
The 2021/2022 Re-Registration Period is now live.
To Re-Register, please click on the 'Re-Registration, Data Entry and Reports/Participant Hub' above. In the new window that opens, please enter your login details, provided to you when you registered. You will then be redirected to the Participant Hub.
To ensure that all programme details are correct, we strongly recommend that you complete the re-registration process. Please note that from April 2021, the Immune Monitoring and Immune Monitoring (Alternative Technologies) programmes will merge and form a single Immune Monitoring programme. Participants will not notice any change to the running of the programme, however, Beckmann Coulter Aquios users will be scored as a separate cohort. For those participants registered in the Immune Monitoring it is further recommended that you complete the re-registration process to ensure that the selected antigens are those that are routinely tested, this will ensure that your performance is monitored for the correct parameters and prevent you being classified as a persistent non-returning laboratory for antigens outside of your testing scope.
For further information on how to re-register, please go to the Actions tab on your Participant Hub and from the Downloads/Resources option select the UK NEQAS LI Re-Registration Guide 2021-22.
If you are registered via a distributor, please contact them directly should you wish to make any changes to your participation or withdraw.
If you encounter any issues with the re-registration process, please contact email@example.com who will be happy to help.
UK NEQAS will soon be hosting a series of scientific webinars from Thursday 8th October! Please see the attached PDF for further details and more information can be found at here.
The RMS is holding an interactive virtual course on flow cytometric data analysis.
This course, which will run over 4 half-days, will cover the basics of analysis for a number of different applications including antibody phenotyping, DNA and cell cycle kinetics, cell proliferation and death, and functional studies. There will also be the opportunity to explore high-dimensional analysis using dimensionality reduction and clustering techniques.
For more information about this course, please click here.
We have been made aware that the recent coronavirus (COVID-19) outbreak is making it difficult for laboratories across the world to deliver core services. With this in mind, we will be extending trial deadlines for all new trials issued by one week. If you are still unable to provide a result within this extended timeframe, or you are unable to return results in currently live trials, please do not hesitate to contact us at firstname.lastname@example.org and we will do everything we can to help.
Due to the current COVID-19 pandemic, the decision has been taken to postpone the Scientific Meeting which had been due to take place in June 2020. This meeting has been re-scheduled for Monday 22nd November 2021 and registration for the meeting will re-open in due course.
We apologise for any inconvenience caused and thank you for your understanding.
RCPath are looking for experienced professionals with experience in technical EQA to join their workstreams.
For further information on this process and details on how to apply please follow this link:
As part of our commitment to develop the services and External Quality Assessment (EQA) programmes provided by this centre we are redesigning the Leukaemia Immunophenotyping (LI) programme to better reflect current hospital laboratory testing protocols. These changes are based on the format and findings from educational exercises A and B, previously issued within this programme.
For more information, please click on the link below.
For information on UK NEQAS LI services and the impact of Brexit, please read our official statement by clicking on the link below.
Sheffield Teaching Hospitals NHS Foundation Trust, a UKAS accredited proficiency testing provider No. 7804, operating UK NEQAS for Leucocyte Immunophenotyping.
You can find our schedule of accreditation here.
Also a link to the UKAS website can be found here, where you will be able to view and download a PDF of our current accreditation certificate.
UK NEQAS for Leucocyte Immunophenotyping (UK NEQAS LI) now has a Facebook page and a Twitter account. We will be posting important messages to these accounts relating to our schemes so please like or follow us, respectively.
We hope that these feeds will act as a useful eductational resource for participants and collaborators alike, collating interesting papers, conference info, videos and news stories in haemato-oncology. As we develop our online presence we hope to publish some of our own educational content. If you have any feedback or ideas as to content you would like us to include, please do not hesitate to get in touch.